2026 NPPES data Hematology & Oncology Physician NPI 1053387266 M.D.
Verify on CMS →

PAUL RICHARDS, M.D.

Hematology & Oncology Physician in SALEM, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
384
Medicare Part D claims · 112 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
71%
generic claims · 29% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.9724/100
▲ 1 pts above national avg 83.1 · [object Object]

What the federal data shows

PAUL RICHARDS, M.D. reported a CMS MIPS final score of 83.9724/100 — above the 83.1 national average — and filed 384 Medicare Part D claims in 2023.

83.9724/100
MIPS score · +1 vs avg
384
Part D claims, 2023
71%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PAUL RICHARDS, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

84 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PAUL RICHARDS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PAUL RICHARDS, M.D.?

Near national average

NPI registry status

Active

Issued 02/27/2006

NPI 1053387266

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

384 55% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

83.9724/100 0.872399999999999% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Virginia

How Hematology & Oncology Physician compares to other specialties among Virginia providers

Virginia providers

Hematology & Oncology Physician share within Virginia

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Virginia

Medicare quality performance — MIPS

PAUL RICHARDS, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
83.9724/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 83.9724/100 vs national avg 83.1

0%100%National avg83%84%
MIPS final score (Hematology & Oncology Physician) — 83.9724/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PAUL RICHARDS, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1900 ELECTRIC RD, SALEM, VA, 24153, with a listed phone of (540) 774-8660. NPI 1053387266 was issued on 02/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RICHARDS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 384 prescription claims written by this provider, covering 112 Medicare beneficiaries and totaling roughly $823K in drug spend, split 29% brand-name and 71% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.9724/100 for the 2023 performance year (Quality 73.8008, Cost 57.1654), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1900 ELECTRIC RD
SALEM, VA 24153

Provider Details

NPI 1053387266
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 02/27/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.9724
Final Score
Avg: 83.1
73.8008
Quality
57.1654
Cost
99
Promoting Interoperability

Reporting: Group practice

Brand vs generic prescribing mix · Above average

PAUL RICHARDS, M.D. — brand share 29.0%
Specialty average (est.)

29% brand-name claims vs 71% generic, on 384 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

384
Total Claims
$823K
Total Drug Cost
112
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
699
Total Day Supply
20,440
Brand vs Generic
29% brand / 71% generic
Brand Drug Cost
$815K
Generic Drug Cost
$8K
Opioid Claims
14 (3.6% rate)

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
2.02
Gender Split
71% female / 29% male
Age Distribution
<65: 11, 65-74: 55, 75-84: 32, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PAUL RICHARDS, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
47
Eliquis
Apixaban
42
Hydroxyurea
26
Jakafi
Ruxolitinib Phosphate
16
Ibrance
Palbociclib
14
Escitalopram Oxalate
13
Ondansetron Hcl
13
Tamoxifen Citrate
12
Anastrozole
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How PAUL RICHARDS, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

PAUL RICHARDS, M.D.'s 384 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Virginia

Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as RICHARDS.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PAUL RICHARDS, M.D.'s specialty?
PAUL RICHARDS, M.D. specializes in Hematology & Oncology Physician and practices in SALEM, Virginia. Credentials: M.D..
How much does PAUL RICHARDS, M.D. prescribe under Medicare Part D?
In 2023, PAUL RICHARDS, M.D. wrote 384 Medicare Part D claims totaling $823K in drug costs for 112 beneficiaries.
What is PAUL RICHARDS, M.D.'s Medicare quality score?
PAUL RICHARDS, M.D. has a CMS MIPS Final Score of 83.9724/100 (Quality: 73.8008, Cost: 57.1654). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PAUL RICHARDS, M.D. located?
PAUL RICHARDS, M.D. is located at 1900 ELECTRIC RD, SALEM, VA, 24153. Phone: (540) 774-8660.
What is PAUL RICHARDS, M.D.'s NPI number?
PAUL RICHARDS, M.D.'s National Provider Identifier (NPI) is 1053387266, issued on 02/27/2006.
Does PAUL RICHARDS, M.D. prescribe more brand-name or generic drugs?
PAUL RICHARDS, M.D.'s prescribing is 29% brand-name and 71% generic drugs by claim count, with $815K in brand drug costs.
Does PAUL RICHARDS, M.D. prescribe opioids?
Yes, PAUL RICHARDS, M.D. had 14 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does PAUL RICHARDS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PAUL RICHARDS, M.D.'s most frequently prescribed drugs include Letrozole, Eliquis, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PAUL RICHARDS, M.D. accept Medicare?
PAUL RICHARDS, M.D. appears in CMS Medicare data with 384 Part D claims and 112 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PAUL RICHARDS, M.D.'s credentials?
PAUL RICHARDS, M.D.'s NPI is 1053387266 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology